Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
NCT ID:
NCT03811834
Pre Assignment Details:
Healthy male participants were enrolled in this 2-period study to receive mobocertinib 160 milligram (mg), capsules followed by carbon-14 \[14C\]-mobocertinib 50 microgram (mcg), infusion in Period 1 (Absolute Bioavailability \[ABA\]) and \[14C\]-mobocertinib 160 mg, solution in Period 2 (Absorption, Distribution, Metabolism, and Elimination \[ADME\]).
Recruitment Details:
Participants took part in the study at 1 investigative site in the United States from 22 January 2019 to 11 March 2019.
Study:
NCT03811834
Study Brief:
Results Section:
NCT03811834